Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Idarubitec 5mg Injection
Manufacturer/Marketed By : UNITED BIOTECH PVT LTD
$94.24 $70.69
Idarubitec 5mg Injection contains the active substance Idarubicin hydrochloride. It is an antineoplastic drug that belongs to the class of medications called anthracyclines. It is used in adults and children...
IDARUBICIN
Active Pharmaceutical Ingredient
Idarubitec 5mg Injection
$94.24
$70.69
Idarubitec 5mg Injection contains the active substance Idarubicin hydrochloride. It is an antineoplastic drug that belongs to the class of medications called anthracyclines. It is used in adults and children to treat acute non-lymphoblastic leukemia (ANLL), also referred to as acute myeloid leukemia (AML). It is also used in adults and children as a second-line treatment for relapsed acute lymphoblastic leukemia (ALL). It works by slowing or stopping the growth of cancer cells in your body. Do not take Idarubitec 5mg Injection if you are allergic to Idarubicin or any other ingredients of this medicine. Inform your physician if you have an infection, liver disease, kidney disease, heart disorder, stomach problems, or are breastfeeding. If your doctor has told you that you have an intolerance to some sugars, contact your doctor before taking this medicinal product. Idarubitec 5mg Injection should not be used in pregnant and breastfeeding women. Inform your physician if you are pregnant or breastfeeding. Use effective contraception throughout the therapy to avoid pregnancy. This medicine may affect male fertility. Talk with your doctor if you are planning for pregnancy. The common side effects are diarrhea, nausea, vomiting, stomach cramps, and hair loss.
Active Pharmaceutical Ingredient
Uses
• Acute myeloid leukemia (AML)
• Relapsed acute lymphoblastic leukemia (ALL)
Benefits
Idarubitec 5mg Injection has antimitotic and cytotoxic effects via a variety of modes of action. It intercalates with DNA to form complexes, and it inhibits topoisomerase II activity by stabilising the DNA-topoisomerase II complex, blocking the relegation component of the ligation-religation reaction catalysed by topoisomerase II. It interferes with the ways in which the cells of your body grow and increase in number and is used in the treatment of cancers.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Abnormal rhythm
• Chest pain
• Congestive heart failure
• Decreased bone marrow function
• Liver toxicity
• Kidney toxicity
• Infections
Common Side Effects
• Hair loss
• Itchy skin rash
• Diarrhea
• Nausea, vomiting
• Stomach cramps
• Headache
How To Use
It will be given to you by a doctor or nurse in a hospital or clinic setting who is trained in cancer chemotherapy. It is given as an intravenous infusion drip (into your vein). Do not self-administer the injection. Your doctor will decide the dose and duration of the treatment based on your disease severity, body weight, and other factors.
Safety Advice
• Breast Feeding: Breastfeeding is not recommended in patients taking Idarubitec 5mg Injection because the medicine passes into the breast milk in small amounts and may harm your baby.
• Alcohol: It is unknown whether consuming alcohol is safe during treatment with Idarubitec 5mg Injection. Inform your doctor if you are a chronic drinker.
• Liver: Idarubitec 5mg Injection should be used with caution in patients with liver disease. Dose adjustments are necessary. Inform your physician if you have any liver problems before initiating the therapy.
• Lungs: It is unknown whether Idarubitec 5mg Injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
• Driving: Idarubitec 5mg Injection may make you feel tired, dizzy, or sleepy. It is unsafe to drive or operate heavy machinery after taking this medicine.
• Pregnancy: Idarubitec 5mg Injection is unsafe to administer in pregnant women because it may affect the fetus. Inform your physician if you are pregnant, suspect pregnant, or planning to become pregnant. Using an effective birth control method during the treatment and for 6.5 months after your last dose is necessary.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.



